Congratulations to Eric A. Hughes, MD, PhD for his prestigious appointment to the Board of Monte Rosa Therapeutics. It is very rewarding to see that the innovative leader of our scientific portfolio has been tapped for this Board position, which speaks volumes about the positive momentum Teva has with its own science under Eric’s leadership.
We are pleased to welcome Eric A. Hughes, MD, PhD, Executive Vice President, Global R&D and Chief Medical Officer of Teva Pharmaceuticals, to Monte Rosa’s Board of Directors. As a seasoned leader in biopharma R&D, his expertise will be invaluable as we continue to advance our pipeline and unlock the potential of molecular glue degrader-based medicines. Markus Warmuth, CEO, shares more: https://bit.ly/3BuP615